6.28
전일 마감가:
$6.29
열려 있는:
$6.29
하루 거래량:
1.31M
Relative Volume:
4.51
시가총액:
$411.09M
수익:
-
순이익/손실:
$-76.41M
주가수익비율:
-3.2708
EPS:
-1.92
순현금흐름:
$-64.56M
1주 성능:
+3.97%
1개월 성능:
+4.84%
6개월 성능:
-24.61%
1년 성능:
-13.74%
Aura Biosciences Inc Stock (AURA) Company Profile
명칭
Aura Biosciences Inc
전화
(617)500-8864
주소
80 GUEST STREET, BOSTON
AURA을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
AURA
Aura Biosciences Inc
|
6.28 | 411.09M | 0 | -76.41M | -64.56M | -1.92 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
441.30 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
521.00 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
322.83 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
560.14 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
241.20 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-05-28 | 재개 | H.C. Wainwright | Buy |
2024-07-25 | 개시 | H.C. Wainwright | Buy |
2023-07-27 | 개시 | Scotiabank | Sector Outperform |
2023-04-17 | 재개 | BTIG Research | Buy |
2022-07-19 | 개시 | JMP Securities | Mkt Outperform |
Aura Biosciences Inc 주식(AURA)의 최신 뉴스
Aura Biosciences Holds 2025 Annual Stockholders Meeting - TipRanks
Non-Muscle Invasive Bladder Cancer Market Set to Grow Substantially Through 2034, DelveInsight Projects | CG Oncology, Pfizer, UroGen Pharma, Janssen Research & Development, LLC, Protara Therapeutics - The Globe and Mail
Harbor Capital Advisors Inc. Takes Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
PTC Brings Cloud-Native Model-Based Definition to Onshape - The Globe and Mail
Company News for Jun 13, 2025 - The Globe and Mail
Bank of America Corp DE Increases Stock Holdings in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Two Sigma Investments LP Reduces Stock Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Kantar appoints Jeff Greenspoon as CEO, Americas - The Globe and Mail
Kernaghan buying at Western Forest Products (WEF) - The Globe and Mail
BNP Paribas Financial Markets Invests $50,000 in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
15,427 Shares in Aura Biosciences, Inc. (NASDAQ:AURA) Acquired by ProShare Advisors LLC - Defense World
Ameriprise Financial Inc. Has $704,000 Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Option Volatility And Earnings Report For June 26 - The Globe and Mail
Learn to Evaluate (AURA) using the Charts - news.stocktradersdaily.com
Brokers Set Expectations for AURA Q2 Earnings - Defense World
Deutsche Bank AG Buys 15,951 Shares of Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Aura Biosciences, Inc. (NASDAQ:AURA) Receives Average Recommendation of “Buy” from Analysts - Defense World
Equities Analysts Offer Predictions for AURA FY2028 Earnings - Defense World
Aura Biosciences (NASDAQ:AURA) Raised to Buy at HC Wainwright - Defense World
H.C. Wainwright sets $22 target for Aura Biosciences stock By Investing.com - Investing.com Canada
Aura Biosciences (AURA) Receives 'Buy' Rating from HC Wainwright & Co. | AURA Stock News - GuruFocus
H.C. Wainwright sets $22 target for Aura Biosciences stock - Investing.com
Aura Biosciences assumed with a Buy at H.C. Wainwright - TipRanks
AURA: Analyst Initiates Buy Rating with $22 Price Target | AURA Stock News - GuruFocus
Innovative Precision Oncology and Promising Clinical Results Justify Buy Rating for Aura Biosciences Inc - TipRanks
Aura Biosciences (NASDAQ:AURA) Earns Market Outperform Rating from JMP Securities - Defense World
Northern Trust Corp Has $3.18 Million Stock Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
JMP maintains $19 target on Aura Biosciences stock after FDA insights - Investing.com Canada
AURA: JMP Securities Reiterates Market Outperform Rating | AURA Stock News - GuruFocus
Strategic Positioning and Regulatory Advantage Bolster Aura Biosciences Inc’s Buy Rating - TipRanks
Finance Watch: Public Company Fundraising Sank Across The Board In Q1 - insights.citeline.com
Anthony Gibney Buys 721% More Aura Biosciences Shares - simplywall.st
Long Term Trading Analysis for (AURA) - news.stocktradersdaily.com
Aura Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Major Stock Moves: Aura Biosciences Inc Sees Insider Buying Spree! - TipRanks
Promising Developments and Strategic Advancements Propel Aura Biosciences Inc’s Buy Rating - TipRanks
Aura Biosciences Advances in Cancer Therapy Trials - TipRanks
Aura Biosciences Raises $69.9 Million in Public Offering - TipRanks
Aura Biosciences announces public offering; shares down - MSN
Aura Biosciences: Strategic Advancements and Clinical Progress Drive Buy Rating - TipRanks
FDA lifts hold on Scynexis trial; Incyte’s Zynyz notches another FDA approval - Endpoints News
Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights - GlobeNewswire
Aura Biosciences Launches Public Offering Of Common Stock And Warrants - Nasdaq
Aura Biosciences announces common stock, warrant offering, no amount given - TipRanks
Aura Biosciences Prices $75 Million Offering of Shares, Warrants - marketscreener.com
Aura Biosciences sets terms for $75 million public offering By Investing.com - Investing.com India
Aura Biosciences sets terms for $75 million public offering - Investing.com Australia
Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants - GlobeNewswire
Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants - Benzinga
Aura Biosciences Secures $75M Funding: Major Push for Precision Cancer Treatment Development - Stock Titan
Aura Biosciences Launches Proposed Public Offering of Shares, Warrants - marketscreener.com
Aura Biosciences Inc (AURA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Aura Biosciences Inc 주식 (AURA) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Johnson David Michael | Director |
May 16 '25 |
Buy |
4.90 |
20,000 |
98,000 |
166,167 |
Gibney Anthony S | See Remarks |
May 16 '25 |
Buy |
4.90 |
50,000 |
245,000 |
58,452 |
Gibney Anthony S | See Remarks |
May 16 '25 |
Sale |
5.15 |
1,519 |
7,823 |
56,933 |
자본화:
|
볼륨(24시간):